Serum Institute of India | Zee News

Advertisement

NewsSerum Institute of India

Serum Institute of India News

Cyrus Poonawalla

16 Jul 2023

Cyrus Poonawalla: The Son Of A Horse Breeder Who Carved His Own Path

Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.

Serum Institute of India

21 Dec 2022

Adar Poonawallah's IMPORTANT MESSAGE amid Covid outbreak in China

Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic. Serum Institute of India is the one who made Covishield covid vaccine.

21 Dec 2022

Rising Covid-19 cases in China 'concerning': Serum Institute's Adar Poonawalla

We must continue to trust and follow the guidelines set by the Government of India, Serum Institute of India (SII) CEO Adar Poonawalla said as he expressed concern over reports of a rising COVID-19 graph in China.

01 Nov 2022

People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO

"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla said.

Adar Poonawalla

11 Sep 2022

Fraudsters dupe SII of Rs 1 cr by asking for money in Poonawalla's name

One of the directors of the SII received WhatsApp messages from a person who posed as Adar Poonawalla. The sender asked him to transfer money to certain bank accounts immediately. Believing that it was the CEO who had messaged, the company officials transferred Rs 1.01 crore.

03 Sep 2022

Man demands Rs 1,000 crore from Covid-19 vaccine makers for daughter's death

A man has filed a petition seeking a response from the makers of Covishield claiming that the vaccine caused his daughter's death He has demanded a compensation of Rs 1,000 crore from the Indian-vaccine maker Serum Institute of India (SII)

25 Jun 2022

Govt panel recommends emergency approval of SII’s Covovax for 7-11 year-olds

"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.

Serum Institute of India

24 May 2022

Serum Institute planning to set up its 1st manufacturing plant in Africa

Serum Institute of India is considering setting up its first manufacturing plant in Africa World`s biggest vaccine maker looks to expand globally after its success in selling Covid-19 shots. 'It`s never been a better time to be a vaccine manufacturer,' SII CEO Adar Poonawalla said at the World Economic Forum.

COVID-19 coronavirus

05 May 2022

Covovax available for everyone above age of 12 years: SII CEO Adar Poonawalla

Adar Poonawalla clarified that the Covid-19 vaccine Covovax is available for everyone above the age of 12 years. Earlier, on Tuesday, SII CEO had informed that Covovax (Novavax) is now available for children in India.

04 Apr 2022

Covovax makes it to Covid vaccine basket, proposed for all kids above 12

Covovax was approved by India's drug regulator for restricted use in emergency situations in adults on December 28. India began inoculating children aged 12-14 from March 16. Biological E's Corbevax is being used to inoculate them.

Serum Institute of India

27 Dec 2021

CDSCO panel recommends emergency use authorisation for Covovax, Corbevax

The DCGI office had granted SII permission to manufacture and stock Covovax on May 17 The World Health Organisation had on December 17 issued emergency use listing for Covovax

Serum Institute of India

17 Dec 2021

WHO approves Serum Institute's COVID vaccine, Covovax

Adar Poonawalla announced the news on Twitter The vaccine is named CovovaxTM

COVID-19 booster shot

02 Dec 2021

SII seeks approval for Covishield vaccine as booster dose amid Omicron scare

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose. The new Omicron variant was first reported to the WHO by South Africa on November 24.

Serum Institute of India

01 Dec 2021

Third jab soon? Serum Institute asks DCGI to allow Covishield as booster dose

SII cited adequate stock of the vaccine in the country and a demand for a booster.

26 Nov 2021

Serum Institute resumes Covishield export to COVAX

The first consignment of Covishield has already left Pune COVAX is an international COVID-19 vaccine sharing platform India will start contributing to COVAX after 8 months

21 Nov 2021

SII requests Centre to fast-track movement of increasing Covishield stock

SII has urged the Centre to fast-track movement of Covishield domestically and globally. SII can export 50 Lakh doses of Covishield under COVAX.

coronavirus vaccine

03 Jul 2021

As India gears up for Moderna, list of other vaccine options available

Moderna will become the fourth vaccine to be available for use in India The Centre plans to provide the Moderna doses directly to states Pfizer will supply one billion doses to India within this year

02 Jul 2021

British PM Boris Johnson says Covishield shot should be accepted in schemes

About 5 million people in Britain are thought to have had the vaccine made by Serum Institute in India India saw a single-day rise of 46,617 new coronavirus infections The death toll due to COVID-19 rose to 4,00,312 with 853 daily fatalities

Serum Institute of India

01 Jul 2021

Complete trial on adults first: Govt panel says no to Covovax trial by SII

Govt panel has said no to Covovax trial by SII The panel has asked it to Complete trials on adults first

04 Jun 2021

Serum Institute gets DCGI nod to manufacture Sputnik V vaccine in India

SII gets DCGI nod to manufacture Sputnik V It has collaborated with Moscow's Gamaleya Research Institute of Epidemiology and Microbiology It will manufacture vaccines at its Hadapsar facility

Loading...

NEWS ON ONE CLICK